🇺🇸 FDA
Patent

US 9333171

Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

granted A61KA61K31/00A61K31/167

Quick answer

US patent 9333171 (Controlled-release CNS modulating compositions and methods for the treatment of otic disorders) held by The Regents of the University of California expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/00, A61K31/167, A61K31/195, A61K31/197